Data gathered: November 18
AI Stock Analysis - Eli Lilly and Company (LLY)
Analysis generated November 10, 2024. Powered by Chat GPT.
Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical corporation with a rich history of developing and marketing innovative medical solutions. The firm’s robust product line includes treatments for conditions such as diabetes, cancer, and immunology. Known for their commitment to scientific research and development, Eli Lilly consistently invests in R&D to sustain their competitive edge and pipeline of new drugs.
Stock Alerts - Eli Lilly and Company (LLY)
 |
Eli Lilly and Company | November 16 Reddit mentions are up by 250% in the last 24h. |
|
Eli Lilly and Company | November 13 Web Traffic is up by 33% over the last month. |
|
Eli Lilly and Company | November 9 Reddit mentions are up by 103% in the last 24h. |
|
Eli Lilly and Company | November 8 Price is up by 5.1% in the last 24h. |
Alternative Data for Eli Lilly and Company
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 997 | Sign up | Sign up | Sign up |
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,288,000 | Sign up | Sign up | Sign up |
| Employee Rating | 82 | Sign up | Sign up | Sign up |
| Google Trends | 25 | Sign up | Sign up | Sign up |
| Patents | 451 | Sign up | Sign up | Sign up |
| 4chan Mentions | 1 | Sign up | Sign up | Sign up |
| Facebook Engagement | 1,933 | Sign up | Sign up | Sign up |
| Facebook Followers | 246,911 | Sign up | Sign up | Sign up |
| Instagram Followers | 39,354 | Sign up | Sign up | Sign up |
| Reddit Mentions | 7 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 36 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 21,964 | Sign up | Sign up | Sign up |
| Twitter Followers | 142,638 | Sign up | Sign up | Sign up |
| Twitter Mentions | 136 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | 40 | Sign up | Sign up | Sign up |
| ESG | 66 | Sign up | Sign up | Sign up |
| Business Outlook | 83 | Sign up | Sign up | Sign up |
| Linkedin Employees | 46,164 | Sign up | Sign up | Sign up |
About Eli Lilly and Company
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
| Price | $727.20 |
| Target Price | Sign up |
| Volume | 9,120,000 |
| Market Cap | $708B |
| Year Range | $722.67 - $960.02 |
| Dividend Yield | 0.7% |
| PE Ratio | 80.67 |
| Analyst Rating | 94% buy |
| Industry | Drug Manufacturers |
In the news
Wolfe Research Initiates Coverage of Eli Lilly and (LLY) with Outperform RecommendationNovember 15 - Fintel |
|
 |
NVS or LLY: Which Is the Better Value Stock Right Now?November 11 - Yahoo |
Eli Lilly and Company (LLY): Ken Fisher’s Bet on a Pharma Giant’s Growth PotentialNovember 10 - Yahoo Entertainment |
|
 |
Sen. Sheldon Whitehouse Buys Eli Lilly and Company (NYSE:LLY) SharesNovember 9 - ETF Daily News |
 |
Eli Lilly and Company (LLY): Among the Best Low Volatility Stocks to Invest In NowNovember 8 - Yahoo |
 |
What Makes Eli Lilly & Co (LLY) a Prospective Investment?November 6 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 11.4B | 4.24B | 7.2B | 970M | 0 | 0.000 |
| Q2 '24 | 11.3B | 4.61B | 6.69B | 2.97B | 4.72B | 3.920 |
| Q1 '24 | 8.77B | 3.51B | 5.26B | 2.24B | 3.21B | 2.580 |
| Q4 '23 | 9.35B | 4.17B | 5.18B | 2.19B | 3.6B | 2.490 |
| Q3 '23 | 9.5B | 3.55B | 5.95B | -57M | 6.4B | 0.100 |
Insider Transactions View All
| LILLY ENDOWMENT INC filed to sell 96,891,978 shares at $969.2. September 4 '24 |
| LILLY ENDOWMENT INC filed to sell 96,892,957 shares at $968.3. September 4 '24 |
| LILLY ENDOWMENT INC filed to sell 96,894,557 shares at $967.3. September 4 '24 |
| LILLY ENDOWMENT INC filed to sell 96,899,877 shares at $966.2. September 4 '24 |
| LILLY ENDOWMENT INC filed to sell 96,916,062 shares at $972.2. August 28 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$154.77 0.5% | 51 |
 |
PfizerPFE |
$24.86 0.2% | 51 |
 |
AstrazenecaAZN |
$63.39 0.3% | 68 |
 |
AbbVieABBV |
$166.28 0.8% | 59 |
 |
TherapeuticsMDTXMD |
$1.29 7.9% | 39 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Nov 7, 24 | Sell | $1K - $15K |
| Jared Moskowitz |
Aug 21, 24 | Buy | $1K - $15K |
| Jared Moskowitz |
Aug 21, 24 | Buy | $1K - $15K |
Read more about Eli Lilly and Company (LLY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Eli Lilly and Company?
The Market Cap of Eli Lilly and Company is $708B.
What is Eli Lilly and Company's PE Ratio?
As of today, Eli Lilly and Company's PE (Price to Earnings) ratio is 80.67.
What is the current stock price of Eli Lilly and Company?
Currently, the price of one share of Eli Lilly and Company stock is $727.20.
How can I analyze the LLY stock price chart for investment decisions?
The LLY stock price chart above provides a comprehensive visual representation of Eli Lilly and Company's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eli Lilly and Company shares. Our platform offers an up-to-date LLY stock price chart, along with technical data analysis and alternative data insights.
Does LLY offer dividends to its shareholders?
Yes, Eli Lilly and Company (LLY) offers dividends to its shareholders, with a dividend yield of 0.7%. This dividend yield represents Eli Lilly and Company's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Eli Lilly and Company in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Eli Lilly and Company?
Some of the similar stocks of Eli Lilly and Company are Johnson & Johnson, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.
.